{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T18:17:48Z","timestamp":1759515468955},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T00:00:00Z","timestamp":1321833600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Prior to the availability of generic third-generation cephalosporins, penicillins were widely used for treatment of pneumococcal meningitis in developing countries despite concerns about rising levels of penicillin resistance among pneumococcal isolates. We examined the impact of penicillin resistance on outcomes of pneumococcal meningitis over a ten year period in an infectious diseases hospital in Brazil.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Clinical presentation, antimicrobial therapy and outcomes were reviewed for 548 patients with culture-confirmed pneumococcal meningitis from December, 1995, to November, 2005. Pneumococcal isolates from meningitis patients were defined as penicillin-resistant if Minimum Inhibitory Concentrations for penicillin were greater than 0.06 \u03bcg\/ml. Proportional hazards regression was used to identify risk factors for fatal outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During the ten-year period, ceftriaxone replaced ampicillin as first-line therapy for suspected bacterial meningitis. In hospital case-fatality for pneumococcal meningitis was 37%. Of 548 pneumococcal isolates from meningitis cases, 92 (17%) were resistant to penicillin. After controlling for age and severity of disease at admission, penicillin resistance was associated with higher case-fatality (Hazard Ratio [HR], 1.62; 95% Confidence Interval [CI], 1.08-2.43). Penicillin-resistance remained associated with higher case-fatality when initial therapy included ceftriaxone (HR, 1.68; 95% CI 1.02-2.76).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Findings support the use of third generation cephalosporin antibiotics for treatment of suspected pneumococcal meningitis even at low prevalence of pneumococcal resistance to penicillins.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2334-11-323","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T07:30:25Z","timestamp":1321947025000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Clinical outcome of pneumococcal meningitis during the emergence of pencillin-resistant Streptococcus pneumoniae: an observational study"],"prefix":"10.1186","volume":"11","author":[{"given":"Edilane L","family":"Gouveia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joice N","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Flannery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraia M","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josilene BT","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo M","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e1tia","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Veronica","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Gloria","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard W","family":"Beall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitermayer G","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert I","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,21]]},"reference":[{"issue":"9693","key":"1694_CR1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","volume":"374","author":"KL O'Brien","year":"2009","unstructured":"O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T: Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009, 374 (9693): 893-902. 10.1016\/S0140-6736(09)61204-6.","journal-title":"Lancet"},{"issue":"2","key":"1694_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1542\/peds.99.2.289","volume":"99","author":"Therapy for children with invasive pneumococcal infections","year":"1997","unstructured":"Therapy for children with invasive pneumococcal infections: American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics. 1997, 99 (2): 289-299.","journal-title":"Pediatrics"},{"issue":"4","key":"1694_CR3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/CMR.11.4.628","volume":"11","author":"SL Kaplan","year":"1998","unstructured":"Kaplan SL, Mason EO: Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev. 1998, 11 (4): 628-644.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"1694_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0163-4453(99)90095-6","volume":"39","author":"N Begg","year":"1999","unstructured":"Begg N, Cartwright KA, Cohen J, Kaczmarski EB, Innes JA, Leen CL, Nathwani D, Singer M, Southgate L, Todd WT, Welsby PD, Wood MJ: Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party. J Infect. 1999, 39 (1): 1-15. 10.1016\/S0163-4453(99)90095-6.","journal-title":"J Infect"},{"key":"1694_CR5","volume-title":"Report of the meeting of 18-20 June 1997","author":"World Health Organization","year":"1997","unstructured":"World Health Organization: Antimicrobial and support therapy for bacterial meningitis in children. Report of the meeting of 18-20 June 1997. 1997, Geneva, Switzerland. HO\/CHD\/98.6; WHO\/EMC\/BAC\/98.2"},{"issue":"9328","key":"1694_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(02)09499-0","volume":"360","author":"GH McCracken Jr","year":"2002","unstructured":"McCracken GH: Rich nations, poor nations, and bacterial meningitis. Lancet. 2002, 360 (9328): 183-10.1016\/S0140-6736(02)09499-0.","journal-title":"Lancet"},{"issue":"11","key":"1694_CR7","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1097\/00006454-200211000-00013","volume":"21","author":"I Mwangi","year":"2002","unstructured":"Mwangi I, Berkley J, Lowe B, Peshu N, Marsh K, Newton CR: Acute bacterial meningitis in children admitted to a rural Kenyan hospital: increasing antibiotic resistance and outcome. Pediatr Infect Dis J. 2002, 21 (11): 1042-1048. 10.1097\/00006454-200211000-00013.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1694_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1179\/146532806X90583","volume":"26","author":"E Molyneux","year":"2006","unstructured":"Molyneux E, Riordan FA, Walsh A: Acute bacterial meningitis in children presenting to the Royal Liverpool Children's Hospital, Liverpool, UK and the Queen Elizabeth Central Hospital in Blantyre, Malawi: a world of difference. Ann Trop Paediatr. 2006, 26 (1): 29-37. 10.1179\/146532806X90583.","journal-title":"Ann Trop Paediatr"},{"key":"1694_CR9","volume-title":"Standardized treatment of bacterial meningitis in Africa in epidemic and non epidemic situations","author":"World Health Organization","year":"2007","unstructured":"World Health Organization: Standardized treatment of bacterial meningitis in Africa in epidemic and non epidemic situations. 2007, WHO\/CDS\/EPR\/2007.3"},{"issue":"9659","key":"1694_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(08)61762-6","volume":"373","author":"A Cameron","year":"2009","unstructured":"Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R: Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009, 373 (9659): 240-249. 10.1016\/S0140-6736(08)61762-6.","journal-title":"Lancet"},{"issue":"1","key":"1694_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1086\/313619","volume":"30","author":"AI Ko","year":"2000","unstructured":"Ko AI, Reis JN, Coppola SJ, Gouveia EL, Cordeiro SM, Lobo TS, Pinheiro RM, Salgado K, Ribeiro Dourado CM, Tavares-Neto J, Rocha H, Galvao Reis M, Johnson WD, Riley LW: Clonally related penicillin-nonsusceptible Streptococcus pneumoniae serotype 14 from cases of meningitis in Salvador, Brazil. Clin Infect Dis. 2000, 30 (1): 78-86. 10.1086\/313619.","journal-title":"Clin Infect Dis"},{"key":"1694_CR12","volume-title":"Meningitis","author":"Secretariat for Health Surveillance","year":"2004","unstructured":"Secretariat for Health Surveillance: Meningitis. 2004, Brasilia, Brazil: Ministry of Health, 7","edition":"7"},{"issue":"1","key":"1694_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1128\/JCM.40.1.275-277.2002","volume":"40","author":"JN Reis","year":"2002","unstructured":"Reis JN, Cordeiro SM, Coppola SJ, Salgado K, Carvalho MG, Teixeira LM, Thompson TA, Facklam RR, Reis MG, Ko AI: Population-based survey of antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from meningitis patients in Salvador, Brazil. J Clin Microbiol. 2002, 40 (1): 275-277. 10.1128\/JCM.40.1.275-277.2002.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1694_CR14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/jcm.32.1.159-163.1994","volume":"32","author":"JH Jorgensen","year":"1994","unstructured":"Jorgensen JH, Ferraro MJ, McElmeel ML, Spargo J, Swenson JM, Tenover FC: Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J Clin Microbiol. 1994, 32 (1): 159-163.","journal-title":"J Clin Microbiol"},{"key":"1694_CR15","volume-title":"CLSI document M100-S18","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: 18th informational supplement. CLSI document M100-S18. 2008, Wayne, PA: Clinical and Laboratory Standards Institute"},{"issue":"8865","key":"1694_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0140-6736(93)92331-M","volume":"342","author":"IR Friedland","year":"1993","unstructured":"Friedland IR, Shelton S, McCracken GH: Chloramphenicol in penicillin-resistant pneumococcal meningitis. Lancet. 1993, 342 (8865): 240-241.","journal-title":"Lancet"},{"issue":"8816","key":"1694_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0140-6736(92)91527-F","volume":"340","author":"KP Klugman","year":"1992","unstructured":"Klugman KP, Koornhof HJ, Friedland IR: Antibiotic resistance in pneumococcal meningitis. Lancet. 1992, 340 (8816): 437-438.","journal-title":"Lancet"},{"issue":"8790","key":"1694_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0140-6736(92)90087-J","volume":"339","author":"IR Friedland","year":"1992","unstructured":"Friedland IR, Klugman KP: Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet. 1992, 339 (8790): 405-408. 10.1016\/0140-6736(92)90087-J.","journal-title":"Lancet"},{"issue":"9","key":"1694_CR19","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/AAC.42.9.2375","volume":"42","author":"D Andes","year":"1998","unstructured":"Andes D, Craig WA: In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations. Antimicrob Agents Chemother. 1998, 42 (9): 2375-2379.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1694_CR20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1542\/peds.83.2.161","volume":"83","author":"MH Lebel","year":"1989","unstructured":"Lebel MH, McCracken GH: Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics. 1989, 83 (2): 161-167.","journal-title":"Pediatrics"},{"issue":"9","key":"1694_CR21","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/00006454-199209000-00002","volume":"11","author":"M Radetsky","year":"1992","unstructured":"Radetsky M: Duration of symptoms and outcome in bacterial meningitis: an analysis of causation and the implications of a delay in diagnosis. Pediatr Infect Dis J. 1992, 11 (9): 694-701. 10.1097\/00006454-199209000-00002.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"1694_CR22","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/adc.88.6.536","volume":"88","author":"T Duke","year":"2003","unstructured":"Duke T, Michael A, Mokela D, Wal T, Reeder J: Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries?. Arch Dis Child. 2003, 88 (6): 536-539. 10.1136\/adc.88.6.536.","journal-title":"Arch Dis Child"},{"issue":"Pt 5","key":"1694_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1099\/jmm.0.46387-0","volume":"55","author":"MC Brandileone","year":"2006","unstructured":"Brandileone MC, Casagrande ST, Guerra ML, Zanella RC, Andrade AL, Di Fabio JL: Increase in numbers of beta-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage. J Med Microbiol. 2006, 55 (Pt 5): 567-574.","journal-title":"J Med Microbiol"},{"issue":"2","key":"1694_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/jac\/dki196","volume":"56","author":"MC Brandileone","year":"2005","unstructured":"Brandileone MC, Casagrande ST, Guerra ML, Zanella RC, de Andrade AL, Di Fabio JL: Increase in penicillin resistance of invasive Streptococcus pneumoniae in Brazil after 1999. J Antimicrob Chemother. 2005, 56 (2): 437-439.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"1694_CR25","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1086\/598975","volume":"48","author":"MP Weinstein","year":"2009","unstructured":"Weinstein MP, Klugman KP, Jones RN: Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance. Clin Infect Dis. 2009, 48 (11): 1596-1600. 10.1086\/598975.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1694_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1086\/377534","volume":"37","author":"VL Yu","year":"2003","unstructured":"Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, Ko WC, Chedid MB, Andremont A, Klugman KP: An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003, 37 (2): 230-237. 10.1086\/377534.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1694_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1089\/10766290152773400","volume":"7","author":"M Hortal","year":"2001","unstructured":"Hortal M, Lovgren M, de la Hoz F, Agudelo CI, Brandileone MC, Camou T, Casagrande S, Castaneda E, Corso A, Echaniz G, Hormazabal JC, Pace J, Palacio R, Perez-Giffoni G, Ruvinsky R, Di Fabio JL: Antibiotic resistance in Streptococcus pneumoniae in six Latin American countries: 1993-1999 surveillance. Microb Drug Resist. 2001, 7 (4): 391-401. 10.1089\/10766290152773400.","journal-title":"Microb Drug Resist"},{"key":"1694_CR28","doi-asserted-by":"crossref","unstructured":"Brouwer MC, Read RC, van de Beek D: Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. 10 (4): 262-274.","DOI":"10.1016\/S1473-3099(10)70045-1"},{"issue":"10","key":"1694_CR29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1086\/522534","volume":"45","author":"H Peltola","year":"2007","unstructured":"Peltola H, Roine I, Fernandez J, Zavala I, Ayala SG, Mata AG, Arbo A, Bologna R, Mino G, Goyo J, Lopez E, de Andrade SD, Sarna S: Adjuvant glycerol and\/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2007, 45 (10): 1277-1286. 10.1086\/522534.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1694_CR30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.idc.2004.04.005","volume":"18","author":"SW Sinner","year":"2004","unstructured":"Sinner SW, Tunkel AR: Antimicrobial agents in the treatment of bacterial meningitis. Infect Dis Clin North Am. 2004, 18 (3): 581-602. 10.1016\/j.idc.2004.04.005. ix","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"1694_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1590\/S1020-49892009000400004","volume":"25","author":"CI Agudelo","year":"2009","unstructured":"Agudelo CI, Castaneda E, Corso A, Regueira M, Brandileone MC, Brandao AP, Maldonado A, Hormazabal JC, Tamargo I, Echaniz-Aviles G, Soto A, Viveros MG, Hernandez I, Chamorro G, Weiler N, Sanchez J, Feris JM, Camou T, Garcia G, Spadola E, Payares D, Gabastou JM, Di Fabio JL: [Resistance to non-beta-lactam antibiotics in the clinical isolates of Streptococcus pneumoniae of children in Latin America. SIREVA II, 2000-2005]. Rev Panam Salud Publica. 2009, 25 (4): 305-313.","journal-title":"Rev Panam Salud Publica"},{"issue":"4","key":"1694_CR32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/107662903322762770","volume":"9","author":"M Castanheira","year":"2003","unstructured":"Castanheira M, Jones RN, Silbert S, Brandileone MC, Sader HS: Typing and molecular characterization of Streptococcus pneumoniae with reduced susceptibility to cefotaxime isolated in Latin America. Microb Drug Resist. 2003, 9 (4): 345-351. 10.1089\/107662903322762770.","journal-title":"Microb Drug Resist"},{"issue":"5","key":"1694_CR33","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1542\/peds.102.5.1087","volume":"102","author":"M Arditi","year":"1998","unstructured":"Arditi M, Mason EO, Bradley JS, Tan TQ, Barson WJ, Schutze GE, Wald ER, Givner LB, Kim KS, Yogev R, Kaplan SL: Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998, 102 (5): 1087-1097. 10.1542\/peds.102.5.1087.","journal-title":"Pediatrics"},{"issue":"9","key":"1694_CR34","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/00006454-200109000-00003","volume":"20","author":"SC Buckingham","year":"2001","unstructured":"Buckingham SC, McCullers JA, Lujan-Zilbermann J, Knapp KM, Orman KL, English BK: Pneumococcal meningitis in children: relationship of antibiotic resistance to clinical characteristics and outcomes. Pediatr Infect Dis J. 2001, 20 (9): 837-843. 10.1097\/00006454-200109000-00003.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1694_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1086\/313606","volume":"30","author":"AE Fiore","year":"2000","unstructured":"Fiore AE, Moroney JF, Farley MM, Harrison LH, Patterson JE, Jorgensen JH, Cetron M, Kolczak MS, Breiman RF, Schuchat A: Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin Infect Dis. 2000, 30 (1): 71-77. 10.1086\/313606.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1694_CR36","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1097\/INF.0b013e3181a74b22","volume":"28","author":"E Castaneda","year":"2009","unstructured":"Castaneda E, Agudelo CI, Regueira M, Corso A, Brandileone MC, Brandao AP, Maldonado A, Hormazabal JC, Martinez IT, Llanes R, Sanchez J, Feris JM, Echaniz-Aviles G, Carnalla-Barajas MN, Terrazas MG, Monroy IH, Chamorro G, Weiler N, Camou T, Gabarrot GG, Spadola E, Payares D, Gabastou JM, Di Fabio JL, de la Hoz F: Laboratory-based surveillance of Streptococcus pneumoniae invasive disease in children in 10 Latin American countries: a SIREVA II project, 2000-2005. Pediatr Infect Dis J. 2009, 28 (9): e265-270. 10.1097\/INF.0b013e3181a74b22.","journal-title":"Pediatr Infect Dis J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-11-323\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T15:43:16Z","timestamp":1639755796000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-11-323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,21]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1694"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-11-323","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,21]]},"assertion":[{"value":"18 February 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"323"}}